Increased levels of β2-microglobulin, soluble interleukin-2 receptor, and soluble CD8 in patients with subacute sclerosing panencephalitis
- 31 October 1992
- journal article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 65 (1), 53-59
- https://doi.org/10.1016/0090-1229(92)90247-l
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Treatment of subacute sclerosing panencephalitis with alpha interferonAnnals of Neurology, 1991
- Beta-2-Microglobulin Levels in the Cerebrospinal Fluid: Their Value as a Disease MarkerEuropean Neurology, 1991
- Soluble interleukin-2 receptor and soluble CD8 antigen in active rheumatoid arthritisClinical Immunology and Immunopathology, 1990
- Immune Activation in MeaslesNew England Journal of Medicine, 1989
- Impaired human leukocyte antigen-restricted measles virus-specific cytotoxic T-cell response in subacute sclerosing panencephalitisAnnals of Neurology, 1989
- Administration of human leukocyte interferon to patients with subacute sclerosing panencephalitisBrain & Development, 1989
- Intraventricular Interferon Treatment for Subacute Sclerosing PanencephalitisJournal of Child Neurology, 1989
- Increased level of cerebrospinal fluid β2-microglobulin is related to neurologic impairment in multiple sclerosisActa Neurologica Scandinavica, 1988
- β2-microglobulin in urine and serum determined by ELIS A techniqueScandinavian Journal of Clinical and Laboratory Investigation, 1984
- Absence of M protein in a cell-associated subacute sclerosing panencephalitis virusNature, 1980